Role of proinflammatory markers and NT-proBNP in patients with an implantable cardioverter-defibrillator and an electrical storm

被引:44
作者
Streitner, Florian [1 ]
Kuschyk, Juergen [1 ]
Veltmann, Christian [1 ]
Ratay, Desiree [1 ]
Schoene, Nina [1 ]
Streitner, Ines [1 ]
Brueckmann, Martina [1 ]
Schumacher, Burghard [2 ]
Borggrefe, Martin [1 ]
Wolpert, Christian [1 ]
机构
[1] Heidelberg Univ, Fac Med, Univ Hosp Mannheim, Dept Med Cardiol 1, D-6800 Mannheim, Germany
[2] Ctr Cardiovasc Med, Dept Cardiol, Bad Neustadt an der Saale, Germany
关键词
Interleukin-6; High-sensitivity C-reactive protein; N-terminal prohormone of B-type natriuretic peptide; Electrical storm; Implantable cardioverter-defibrillator; C-REACTIVE PROTEIN; LEFT-VENTRICULAR DYSFUNCTION; BRAIN NATRIURETIC PEPTIDE; MYOCARDIAL-INFARCTION; INDEPENDENT PREDICTOR; INFLAMMATORY MARKERS; ATRIAL-FIBRILLATION; ICD-RECIPIENTS; RISK; INTERLEUKIN-6;
D O I
10.1016/j.cyto.2009.06.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Several studies have attempted to identify risk factors for the development of an electrical storm (ES), which is defined as >= 3 separate ventricular tachyarrhythmic (VT/VF) events, but in the majority of studies no triggers have been found. However, little is known about the role of inflammation and NT-proBNP in patients with ES. The aim of this study was therefore to assess the relationship of Interleukin-6 (IL-6), high-sensitivity C-reactive protein (hs-CRP) and NT-proBNP serum concentrations in ICD-patients with or without single spontaneous ventricular tachyarrhythmic events (VT/VF) and in ES. Methods: Markers were determined in 51 patients without ICD-intervention, in 15 ICD-patients with single VT/VF-episodes during 9-months follow-up and in 20 ICD-patients with ES (blood sampling performed within 60 min after fulfilling ES criteria). VT/VF-episodes were analysed by stored ICD-electrograms. Results: All patients had idiopathic dilated cardiomyopathy (n = 23) or coronary artery disease (n = 63). Patients with ES revealed significantly higher mean serum concentrations of all markers (IL-6 15.19 +/- 10.34 pg/mL, hs-CRP 20.12 +/- 14.4 mg/L, NT-proBNP 4799 4596 pg/mL) compared to baseline values of patients with single VT/VF-events during follow-up (IL-6 8.37 +/- 5.8 pg/mL (p = 0.03), hs-CRP 4.7 +/- 5.3 mg/dL (p < 0.001), NT-proBNP 1913 +/- 2665 pg/mL (p = 0.04)) and compared to baseline values of ICD-patients without device intervention (IL-6 4.62 +/- 3.66 pg/mL (p < 0.001), hs-CRP 4.1 +/- 3.4 mg/L (p < 0.001), NT-proBNP 1461 +/- 2281 pg/mL (p < 0.001)). In 9/20 patients presenting with ES (45%) baseline values were available. All markers were significantly higher during ES compared to event-free determination (IL-6 14.54 +/- 10.43 vs. 7.03 +/- 2.83 pg/mL (p = 0.04), hs-CRP 19.07 +/- 16.07 vs. 6.5 +/- 3.9 mg/L (p = 0.02), NT-proBNP 4218 +/- 2561 vs. 2099 +/- 1279 pg/mL (p = 0.03)). Conclusions: Electrical storm is associated with significantly elevated IL-6, hs-CRP and NT-proBNP serum concentrations in ICD-patients with structural heart disease. Thus, ES may be triggered by proinflammatory activity. Combined intraindividual elevation of determined markers might help to identify patients at risk of impending electrical storm. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:166 / 172
页数:7
相关论文
共 41 条
  • [1] Inflammation as a risk factor for atrial fibrillation
    Aviles, RJ
    Martin, DO
    Apperson-Hansen, C
    Houghtaling, PL
    Rautaharju, P
    Kronmal, RA
    Tracy, RP
    Van Wagoner, DR
    Psaty, BM
    Lauer, MS
    Chung, MK
    [J]. CIRCULATION, 2003, 108 (24) : 3006 - 3010
  • [2] C reactive protein is associated with malignant ventricular arrhythmias in patients with ischaemia with implantable cardioverter-defibrillator
    Biasucci, L. M.
    Giubilato, G.
    Biondi-Zoccai, G.
    Sanna, T.
    Liuzzo, G.
    Piro, M.
    De Martino, G.
    Ierardi, C.
    dello Russo, A.
    Pelargonio, G.
    Bellocci, F.
    Crea, F.
    [J]. HEART, 2006, 92 (08) : 1147 - 1148
  • [3] Serum BNP, hs-C-reactive protein, procollagen to assess the risk of ventricular tachycardia in ICD recipients after myocardial infarction
    Blangy, Hugues
    Sadoul, Nicolas
    Dousset, Brigitte
    Radauceanu, Anca
    Fay, Renaud
    Aliot, Etienne
    Zannad, Faiez
    [J]. EUROPACE, 2007, 9 (09): : 724 - 729
  • [4] Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter defibrillators
    Brigadeau, F
    Kouakam, C
    Klug, D
    Marquié, C
    Duhamel, A
    Mizon-Gérard, F
    Lacroix, D
    Kacet, S
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 (06) : 700 - 707
  • [5] B-type natriuretic peptide levels predict event-free survival in patients with implantable cardioverter defibrillators
    Christ, Michael
    Sharkova, Julia
    Bayrakcioglu, Somer
    Herzum, Ileana
    Mueller, Christian
    Grimm, Wolfram
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2007, 9 (03) : 272 - 279
  • [6] C-reactive protein elevation in patients with atrial arrhythmias - Inflammatory mechanisms and persistence of atrial fibrillation
    Chung, MK
    Martin, DO
    Sprecher, D
    Wazni, O
    Kanderian, A
    Carnes, CA
    Bauer, JA
    Tchou, PJ
    Niebauer, MJ
    Natale, A
    Van Wagoner, DR
    [J]. CIRCULATION, 2001, 104 (24) : 2886 - 2891
  • [7] Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials
    Connolly, SJ
    Hallstrom, AP
    Cappato, R
    Schron, EB
    Kuck, KH
    Zipes, DP
    Greene, HL
    Boczor, S
    Domanski, M
    Follmann, D
    Gent, M
    Roberts, RS
    [J]. EUROPEAN HEART JOURNAL, 2000, 21 (24) : 2071 - 2078
  • [8] Inflammation, arrhythmia burden and the thrombotic consequences of atrial fibrillation
    Conway, DSG
    Lip, GYH
    [J]. EUROPEAN HEART JOURNAL, 2004, 25 (19) : 1761 - 1761
  • [9] Electrical storm in patients with transvenous implantable cardioverter-defibrillators - Incidence, management and prognostic implications
    Credner, SC
    Klingenheben, T
    Mauss, O
    Sticherling, C
    Hohnloser, SH
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (07) : 1909 - 1915
  • [10] Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation
    Dernellis, J
    Panaretou, M
    [J]. EUROPEAN HEART JOURNAL, 2004, 25 (13) : 1100 - 1107